U.S. Markets closed

Alere Inc. (ALR)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
50.17-0.06 (-0.12%)
At close: 4:02PM EDT
People also watch
BIOHAEPODDHOLXCRL
Full screen
Previous Close50.23
Open50.20
Bid0.00 x
Ask0.00 x
Day's Range50.14 - 50.25
52 Week Range31.47 - 50.30
Volume1,523,885
Avg. Volume2,114,857
Market Cap4.38B
Beta-0.64
PE Ratio (TTM)-20.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube5 days ago

    ETFs with exposure to Alere, Inc. : June 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alere, Inc. Here are 5 ETFs with the largest exposure to ALR-US. Comparing the performance and risk of Alere, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Alere, Inc. :ALR-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017
    Capital Cube6 days ago

    Alere, Inc. :ALR-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Alere, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Alere, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Abbott Laboratories, Chembio Diagnostics, Inc., Danaher Corporation, Procter & Gamble Company, Hill-Rom Holdings, Inc., OraSure Technologies, Inc., Meridian Bioscience, ... Read more (Read more...)

  • American City Business Journals10 days ago

    Alere says feds won’t take action in billing probe

    Waltham diagnostics firm Alere said Wednesday that the U.S. Department of Justice has closed an investigation into the company’s billing practices without filing any charges. Alere (ALR), which has agreed to be acquired by Abbott Laboratories (ABT), said in a first-quarter earnings release that the DOJ informed the company on June 8 that it would not take legal action. The investigation first came to light in July 2016, when the Wall Street Journal reported that Alere had received a criminal subpoena seeking records from its toxicology unit.